Australia, Singapore Pledge Commitment to Further Scientific Collaboration Singapore’s Agency for Science, Technology and Research and Australia’s National Health and Medical Research Council have signed a Memorandum of Understanding to promote exchange between the two countries in the areas of health and medical research. [Agency for Science, Technology and Research] Press Release Pathfinder, LLC and SyntheMed, Inc. Complete Merger SyntheMed, Inc. and Pathfinder, LLC announced the completion of their merger, effective September 2, 2011. [PR Newswire] Press Release Stem Cell Efforts to Treat Neurological Disease Bolstered with $4.5 Million The laboratory headed by Steven Goldman, M.D., Ph.D. has received $4.5 million in new funding to further its efforts to use stem cells and related molecules to treat several feared disorders for which there are currently no cures. [University of Rochester Medical Center] Press Release Bolli Receives $12.8 Million NIH Grant Renewal for Adult Stem Cell Project University of Louisville cardiologist and researcher Roberto Bolli has received a $12.8 million renewal grant from the National Institutes of Health (NIH) for continued research with adult stem cells. [University of Louisville] Press Release Mesoblast Receives Clearance to Begin First European Trial of Allogeneic or ‘Off-The-Shelf’ Stem Cell Treatment for Heart Attacks Mesoblast Limited announced that it had received clearance from the European Medicines Agency to begin a 225-patient multi-center Phase II clinical trial in Europe for its lead cardiovascular product Revascor™ in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack. [Mesoblast Limited] Press Release Pluristem’s PLX Cells Found to Have Potential to Treat Acute Radiation Syndrome Pluristem Therapeutics Inc. announced that animal studies it has conducted suggest that its PLacental eXpanded (PLX) cells are potentially effective in treating life threatening hematopoietic complications associated with Acute Radiation Syndrome. [Pluristem Therapeutics Inc.] Press Release ZenBio, Inc. Awarded a Phase I SBIR Grant to Develop Drug Screening Platform with Human Skeletal Muscle Stem Cells ZenBio, Inc. announced that it has been awarded a Phase I SBIR grant to develop assays using human skeletal muscle stem cells. [ZenBio, Inc.] Press Release
iPierian Appoints Nancy Stagliano as CEO. Peter Van Vlasselaer, Interim CEO, Becomes Executive Chairman of the Board iPierian, Inc., announced that it has appointed Nancy E. Stagliano, PhD as its Chief Executive Officer (CEO). The company’s interim CEO, Peter Van Vlasselaer, PhD will become Executive Chairman of the Board of Directors. [iPierian, Inc.] Press Release |